Anupam Rasayan Launches ₹829 Crore Open Offer for Bliss GVS Pharma

Anupam Rasayan India Limited announced a mandatory open offer to acquire up to 2,77,26,848 shares of Bliss GVS Pharma Limited, representing 26.00% of the latter’s expanded voting share capital. The offer price is set at ₹299.00 per share, valuing the potential acquisition at approximately ₹829 crore.

The open offer is triggered by recent transactions involving Anupam Rasayan and falls under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations. Details were disclosed in a regulatory filing to the National Stock Exchange today.

Notably, the company stated the offer is unconditional and does not have any minimum acceptance criteria; meaning the acquisition will proceed regardless of how many shares are tendered. The current shareholding pattern of Anupam Rasayan in Bliss GVS Pharma was not detailed in the filing.

Analysts view the move as potentially positive for both companies, assigning it a bullish impact score of 6/10. Further details regarding post-acquisition integration plans were not immediately available.

This report was drafted automatically from an exchange filing and is pending editorial review.